No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs554045283 |
chr2:133280661-133280662 |
Enhancers Weak transcription
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs140096163 |
chr2:133280730-133280731 |
Enhancers Weak transcription
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs143674975 |
chr2:133280793-133280794 |
Enhancers Weak transcription
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs551118129 |
chr2:133280817-133280818 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs191973397 |
chr2:133280834-133280835 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs11898943 |
chr2:133280843-133280844 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs565064826 |
chr2:133280846-133280847 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs184719387 |
chr2:133280852-133280853 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs547673184 |
chr2:133280884-133280885 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs11898952 |
chr2:133280890-133280891 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
11 |
rs530060385 |
chr2:133280916-133280917 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs534519241 |
chr2:133280932-133280933 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs146808452 |
chr2:133280981-133280982 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs567587966 |
chr2:133281002-133281003 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs377481588 |
chr2:133281007-133281008 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs538303006 |
chr2:133281032-133281033 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs577005044 |
chr2:133281041-133281042 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs77971076 |
chr2:133281051-133281052 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs367952721 |
chr2:133281061-133281062 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs571764506 |
chr2:133281180-133281181 |
Enhancers Weak transcription
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs12613678 |
chr2:133281214-133281215 |
Enhancers Weak transcription
|
TF binding regionlncRNA
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
22 |
rs553992046 |
chr2:133281319-133281320 |
Enhancers Weak transcription
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs572383027 |
chr2:133281464-133281465 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs542948321 |
chr2:133281478-133281479 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs552148466 |
chr2:133281499-133281500 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs190357521 |
chr2:133281506-133281507 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs370256887 |
chr2:133281511-133281512 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs575972633 |
chr2:133281519-133281520 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs145139077 |
chr2:133281526-133281527 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs564839963 |
chr2:133281552-133281553 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs577050980 |
chr2:133281569-133281570 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs541222903 |
chr2:133281614-133281615 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs559612547 |
chr2:133281616-133281617 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs529998358 |
chr2:133281645-133281646 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs548202020 |
chr2:133281686-133281687 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs374212783 |
chr2:133281690-133281691 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs531610552 |
chr2:133281712-133281713 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs550207399 |
chr2:133281726-133281727 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs553079490 |
chr2:133281734-133281735 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs571404496 |
chr2:133281744-133281745 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs538776764 |
chr2:133281775-133281776 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs182547580 |
chr2:133281778-133281779 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs10183993 |
chr2:133281790-133281791 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
44 |
rs556964391 |
chr2:133281797-133281798 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs536925787 |
chr2:133281813-133281814 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs370333541 |
chr2:133281888-133281889 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs149108613 |
chr2:133281894-133281895 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs536630810 |
chr2:133281924-133281925 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs371158090 |
chr2:133281942-133281943 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs534925422 |
chr2:133281967-133281968 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|